Patrick Hargutt
Founder at Stanley Capital Partners LLP
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Simon Cottle | M | 48 |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland.
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France.
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 5 years |
James Brooks | M | 46 |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 5 years |
Arianna Nardelli | F | - |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 2 years |
Matt Harrison | M | - |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 3 years |
Karine Pinon | F | - |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | 9 years |
Amber Hilkene | F | - |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 1 years |
Dominique Monnet | M | 65 |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | - |
Laura Nazaria | F | - |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | - |
Rodolphe Louvet | M | - |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 2 years |
Adrian Radzyminski | M | - |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 1 years |
Yair Erez | M | 50 |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 2 years |
James Sexton | M | - |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 1 years |
Sharon Curran | F | 56 |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | - |
John McLaughlin | M | 72 |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | - |
Birgit Vogel-Heuser | M | 63 |
Technische Universität München
| 15 years |
Philipp Rösler | M | 51 |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | - |
Cliff Hemingway | M | - |
Stanley Lab, Inc.
| - |
James Strang | M | 52 |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 1 years |
Alan Markey | M | - |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | 7 years |
Hans-Jürgen Leuchs | M | 74 |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | - |
Peter Klaus | M | 80 |
Technische Universität München
| 15 years |
Frederik Fogtdal | M | - |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Johannes Fischer | M | - |
Technische Universität München
| 11 years |
Christian Schubert | M | - |
Technische Universität München
| 5 years |
Lennart Stoltenberg | M | - |
Technische Universität München
| 6 years |
Katharina Frie | F | - |
Technische Universität München
| 6 years |
Mark Windeknecht | M | - |
Technische Universität München
| 11 years |
Nadine Geiser | M | - |
Technische Universität München
| 6 years |
Andreas Kronthaler | M | - |
Technische Universität München
| 7 years |
Marc Al-Hames | M | 46 |
Technische Universität München
| 8 years |
Andreas Unseld | M | - |
Technische Universität München
| 7 years |
Martin Weese | M | 38 |
Technische Universität München
| 6 years |
Andreas Gabl | M | - |
Technische Universität München
| 4 years |
Hana Besbes | F | - |
Technische Universität München
| 6 years |
Martin Klima | M | - |
Technische Universität München
| 5 years |
Björn-Eric Förster | M | 46 |
Technische Universität München
| 2 years |
Sascha Steck | M | - |
Technische Universität München
| 3 years |
Sascha Gunther | M | - |
Technische Universität München
| 3 years |
Aurelia Maurath | F | - |
Technische Universität München
| 3 years |
Bernd Mühlfriedel | M | 53 |
Technische Universität München
| 3 years |
Christian Osterland | M | - |
Technische Universität München
| 3 years |
Ahmed Al-Chalabi | M | - |
Technische Universität München
| 1 years |
Silvan Tuerkcan | M | - |
Technische Universität München
| 2 years |
Emil Zawadzki | M | - |
Technische Universität München
| 3 years |
Stefan Grabmann | M | - |
Technische Universität München
| 4 years |
Jörg Haller | M | 42 |
Technische Universität München
| 4 years |
Radu Bogdan Rusu | M | - |
Technische Universität München
| - |
Hauke Heibel | M | - |
Technische Universität München
| 3 years |
Simon Luca Martinelli | M | - |
Technische Universität München
| 3 years |
Robert Fortmeier | M | 37 |
Technische Universität München
| 3 years |
Wolfgang Arnold | M | 82 |
Technische Universität München
| 15 years |
Laurent Key | M | - |
Technische Universität München
| 2 years |
Gregor Haidl | M | - |
Technische Universität München
| 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 33 | 62.26% |
United Kingdom | 12 | 22.64% |
Ireland | 6 | 11.32% |
France | 3 | 5.66% |
United States | 1 | 1.89% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Patrick Hargutt
- Personal Network